StockData
Nanobiotix S.A. logo

Nanobiotix S.A. (NBTX) stock

NBTXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NNBXF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$27.45−1.09 (-3.82%)

Close on Nov 17, 2026Market cap $1.33BP/E –Yield –

Nanobiotix operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2025 it was -33.2%, against -74.0% the year before. The highest annual figure on record is -33.2% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-33.2%+40.8
FY2023Dec 31, 2023-74.0%+903.9
FY2022Dec 31, 2022-977.8%+1008.5
FY2021Dec 31, 2021-1986.4%−536.2
FY2020Dec 31, 2020-1450.2%+390.8
FY2019Dec 31, 2019-1841.0%−976.7
FY2018Dec 31, 2018-864.2%–

More Nanobiotix figures

See a number that looks wrong?